593 Treating chronic hepatitis C with peginterferon alpha-2a (40KD) (PEGASYS®) plus ribavirin in routine clinical practice: Factors predicting SVR using multiple logistic regression analysis
Saved in:
| Title: | 593 Treating chronic hepatitis C with peginterferon alpha-2a (40KD) (PEGASYS®) plus ribavirin in routine clinical practice: Factors predicting SVR using multiple logistic regression analysis |
|---|---|
| Authors: | Lee, S.S., Powis, J., Heathcote, E.J., Sherman, M., Bailey, R.J., Feinman, S.V., Baro, V., Yoshidas, E., Witt-Sullivan, H.B., Peltekian, K. |
| Source: | Journal of Hepatology. Feb2006 Supplement 2, Vol. 44, pS220-S220. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 01688278 |
|---|---|
| DOI: | 10.1016/s0168-8278(06)80593-3 |
